Eating and hypothalamus changes in behavioral-variant frontotemporal dementia
- PMID: 21387376
- PMCID: PMC3084499
- DOI: 10.1002/ana.22244
Eating and hypothalamus changes in behavioral-variant frontotemporal dementia
Abstract
Objective: Behavioral-variant frontotemporal dementia (bvFTD) is a progressive neurodegenerative brain disorder, clinically characterized by changes in cognition, personality, and behavior. Marked disturbances in eating behavior, such as overeating and preference for sweet foods, are also commonly reported. The hypothalamus plays a critical role in feeding regulation, yet the relation between pathology in this region and eating behavior in FTD is unknown. This study aimed to address this issue using 2 complementary approaches.
Methods: First, 18 early stage bvFTD patients and 16 healthy controls underwent high-resolution structural magnetic resonance imaging and assessment of eating behavior. Hypothalamic volumes were traced manually on coronal images. Second, postmortem analyses of 12 bvFTD cases and 6 matched controls were performed. Fixed hypothalamic tissue sections were stained for a cell marker and for peptides regulating feeding behaviors using immunohistochemistry. Stereological estimates of the hypothalamic volume and the number of neurons and glia were performed.
Results: Significant atrophy of the hypothalamus in bvFTD was present in both analyses. Patients with high feeding disturbance exhibited significant atrophy of the posterior hypothalamus. Neuronal loss, which was observed only in bvFTD cases with Tar DNA protein-43 deposition, was also predominant posteriorly. In contrast, orexin (hypocretin), neuropeptide Y, cocaine- and amphetamine-regulating transcript, and vasopressin-containing neurons that regulate appetite were spared in posterior nuclei known to participate in feeding regulation.
Interpretation: Degeneration and consequent dysregulation within the hypothalamus relates to significant feeding disturbance in bvFTD. These findings provide a basis for the development of therapeutic models.
Copyright © 2010 American Neurological Association.
Figures
![FIGURE 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3084499/bin/ana0069-0312-f1.gif)
![FIGURE 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3084499/bin/ana0069-0312-f2.gif)
![FIGURE 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3084499/bin/ana0069-0312-f3.gif)
![FIGURE 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3084499/bin/ana0069-0312-f4.gif)
Similar articles
-
Eating disturbance in behavioural-variant frontotemporal dementia.J Mol Neurosci. 2011 Nov;45(3):589-93. doi: 10.1007/s12031-011-9547-x. Epub 2011 May 17. J Mol Neurosci. 2011. PMID: 21584651 Review.
-
Eating behavior in frontotemporal dementia: Peripheral hormones vs hypothalamic pathology.Neurology. 2015 Oct 13;85(15):1310-7. doi: 10.1212/WNL.0000000000002018. Epub 2015 Sep 16. Neurology. 2015. PMID: 26377252 Free PMC article.
-
Detailed volumetric analysis of the hypothalamus in behavioral variant frontotemporal dementia.J Neurol. 2015 Dec;262(12):2635-42. doi: 10.1007/s00415-015-7885-2. Epub 2015 Sep 4. J Neurol. 2015. PMID: 26338813 Free PMC article.
-
Assessment of Eating Behavior Disturbance and Associated Neural Networks in Frontotemporal Dementia.JAMA Neurol. 2016 Mar;73(3):282-90. doi: 10.1001/jamaneurol.2015.4478. JAMA Neurol. 2016. PMID: 26810632
-
Hypothalamic symptoms of frontotemporal dementia disorders.Handb Clin Neurol. 2021;182:269-280. doi: 10.1016/B978-0-12-819973-2.00019-8. Handb Clin Neurol. 2021. PMID: 34266598 Review.
Cited by
-
Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence.Physiol Behav. 2024 Jul 1;281:114565. doi: 10.1016/j.physbeh.2024.114565. Epub 2024 Apr 23. Physiol Behav. 2024. PMID: 38663460 Free PMC article. Review.
-
AI-assisted quantification of hypothalamic atrophy in amyotrophic lateral sclerosis by convolutional neural network-based automatic segmentation.Sci Rep. 2023 Dec 6;13(1):21505. doi: 10.1038/s41598-023-48649-6. Sci Rep. 2023. PMID: 38057503 Free PMC article.
-
Behavioral and Neuropathological Phenotyping of the Tau58/2 and Tau58/4 Transgenic Mouse Models for FTDP-17.Life (Basel). 2023 Oct 20;13(10):2088. doi: 10.3390/life13102088. Life (Basel). 2023. PMID: 37895469 Free PMC article.
-
Hypothalamic volume is associated with body mass index.Neuroimage Clin. 2023;39:103478. doi: 10.1016/j.nicl.2023.103478. Epub 2023 Jul 24. Neuroimage Clin. 2023. PMID: 37558541 Free PMC article.
-
Charting the Next Road Map for CSF Biomarkers in Alzheimer's Disease and Related Dementias.Neurotherapeutics. 2023 Jul;20(4):955-974. doi: 10.1007/s13311-023-01370-8. Epub 2023 Jun 28. Neurotherapeutics. 2023. PMID: 37378862 Free PMC article. Review.
References
-
- Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology. 2002;58:1615–1621. - PubMed
-
- Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–1554. - PubMed
-
- Pickering-Brown SM. Progranulin and frontotemporal lobar degeneration. Acta Neuropathol. 2007;114:39–47. - PubMed
-
- Goedert M, Spillantini MG, Cairns NJ, Crowther RA. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron. 1992;8:159–168. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical